Table 1.
Baseline details of studies.
Standard graphical abstract | Three facts and a story | |
---|---|---|
Type | ||
Original | 29 (94%) | 21 (91%) |
Review | 2 (6%) | 3 (9%) |
| ||
Clinical science | 17 (55%) | 14 (61%) |
| ||
Clinical trial | 3 (10%) | 1 (4%) |
| ||
Topic | ||
Non-alcoholic fatty liver disease | 2 (6%) | 1 (4%) |
Alcohol-related liver disease | 0 (0%) | 1 (4%) |
Viral hepatitis | 5 (16%) | 5 (17%) |
Autoimmune hepatitis | 0 (0%) | 1 (4%) |
Cholestatic liver disease | 2 (6%) | 0 (0%) |
Cirrhosis management | 5 (16%) | 3 (13%) |
Liver cancer | 7 (23%) | 8 (35%) |
Metabolism/signaling | 6 (19%) | 5 (22%) |
Liver transplant | 3 (10%) | 0 (0%) |